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Abstract
Purpose
The purpose of this study was to compare the effect of treating skeletal muscle cells with
media conditioned by postprandial ex vivo human serum fed with either isonitrogenous Non-
Essential Amino Acid (NEAA) or a whey protein hydrolysate (WPH) on stimulating Muscle
Protein Synthesis (MPS) in C2C12 skeletal muscle cells.
Methods
Blood was taken from six young healthy males following overnight fast (fasted) and 60 min
postprandial (fed) ingestion of either WPH or NEAA (0.33 g.kg-1 Body Mass). C2C12 myo-
tubes were treated with media conditioned by ex vivo human serum (20%) for 4 h. Activation
of MPS signalling (phosphorylation of mTOR, P70S6K and 4E-BP1) were determined in
vitro by Western Blot and subsequent MPS were determined in vitro by Western Blot and
surface sensing of translation technique (SUnSET) techniques, respectively.
Results
Media conditioned by NEAA fed serum had no effect on protein signalling or MPS compared
to fasted, whereas media conditioned by WPH fed serum significantly increased mTOR
(Ser2448), P70S6K and 4E-BP1 phosphorylation (p<0.01, p<0.05) compared to fasted
serum. Furthermore, the effect of media conditioned by WPH fed serum on protein signalling
and MPS was significantly increased (p<0.01, p<0.05) compared to NEAA fed serum.
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Conclusion
In summary, media conditioned by NEAA fed serum did not result in activation of MPS.
Therefore, these in vitro findings suggest the use of isonitrogenous NEAA acts as an effec-
tive control for comparing bioactivity of different proteins on activation of MPS.
1. Introduction
Muscle protein synthesis (MPS) is integral to the repair, growth and maintenance of skeletal
muscle and sensitive to nutrient ingestion. Several studies have assessed the role of protein and
amino acids in the regulation of MPS [1–4]. The importance of appropriate controls in estab-
lishing the bioactivity of compounds in human MPS studies has been emphasised in recent
reviews by Morton et al. [5] and Phillips [6]. These meta-analyses include many studies report-
ing on the effects of amino acid and protein supplementation on MPS which use either a less
appropriate (including carbohydrate and collagen) or no feeding control/placebo [5,7,8]. Fur-
thermore, the European Food Safety Authority (EFSA) advises “human intervention studies
assessing the effect of a specific protein source/constituent against another isonitrogenous pro-
tein source/constituent were considered as pertinent to the claim, whereas studies controlling
for energy only (e.g. using isocaloric carbohydrate sources as placebo) could not be used for
the scientific substantiation of these claims" [9] as comparisons of a test protein to isoenergetic,
but not isonitrogenous carbohydrate control is more likely to show an effect of protein supple-
mentation [6]. Therefore, validation of appropriate non-bioactive isonitrogenous controls is
important for the future evaluation of bioactivity of protein formulations.
Studies assessing the role of protein and amino acids in the regulation of MPS establish a
close relationship between the extracellular concentration of essential amino acids (EAA) and
the rate of MPS [2,10,11], and leucine as the most potent in in vitro [12] and human studies
[8,13–16]. The efficacy of protein and/or amino acid intake to stimulate MPS thereby depends
on the pattern and magnitude of change in extracellular EAA evoked following ingestion that,
in turn, is dependent on the type, amount and timing of protein or amino acid ingestion. Pre-
vious studies also indicate that co-ingestion of non-essential amino acids (NEAA) is surplus to
requirement to stimulate MPS when EAA are present [1–4,17] which is, perhaps, unsurprising
as NEAA are considered readily available in plasma, interstitial and intracellular muscle com-
partments. Therefore, a balanced mix of NEAA may also act as an appropriate isonitrogenous
control (null) to assess the effect of specific proteins on MPS in humans.
We have recently developed a muscle cell-based model to evaluate the MPS response to
ingestion of milk proteins and their derivatives [18]. In this model, conditioning media with
human serum resulted in an increase in MPS in fully differentiated C2C12 skeletal muscle
cells. Furthermore, it was also possible to demonstrate that conditioning media with human
serum sampled 60 min post-ingestion of whey protein stimulated MPS in mature C2C12 myo-
tubes to a greater extent than serum sampled after an overnight fast [18]. Whey is a high EAA
(~50% EAA) containing, soluble milk protein proven to stimulate MPS in young and elderly
populations [19,20]. Ingestion of ~ 0.33g.kg-1 body mass whey protein results in post-ingestion
aminoacidaemia and an increase in circulating EAA of approximately 3-fold within 60 min
[18]. Though equivocal, it seemed plausible to suggest the augmented MPS response of myo-
tubes exposed to ‘fed’ vs. ‘fasted’ serum conditioned media was due to the increase in circulat-
ing EAA in fed serum and that a similar aminoacidaemia through increase in [NEAA] would
not result in an increase in MPS. To test this hypothesis, we fed a NEAA formulation designed
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by Norton et al. (in review), isonitrogenous to whey protein, to human participants. Using the
C2C12 in vitro model established previously [18], serum sampled pre- and post-feeding was
used to condition media of C2C12 myotubes to evaluate change in intracellular signalling and
MPS. The purpose of this study was to evaluate i) if treating skeletal muscle cells with media
conditioned by human serum fed a NEAA formulation resulted in increased intracellular sig-
nalling and MPS and (ii) if media conditioned by human serum fed a NEAA formulation was
comparable to the effect of media conditioned by human serum fed WPH.
2. Materials and methods
2.1 Ethical approval
The study was approved by the local ethics committee at the University of Limerick (EHS-
REC_2013_01_13) and conformed to the standards set by the Declaration of Helsinki. Six
young healthy male participants, (26±4.7 y; 77.7±10.1 kg, 1.77±0.08 m, 25±3.3 kg�m-2, 19
±6.9% BF) agreed to participate in the study, gave informed written consent and completed
the intervention trial.
2.2 Study design
Participants reported to the lab following an overnight fast (>10 h) and having not exercised
in the previous 24 h on two separate occasions, separated by at least 7 d. A blood sample from
the antecubital vein was collected at baseline (t = 0 min) by a clinical nurse on each day as
described previously [18]. Administered double blind participants consumed 0.33 g.kg-1 body
mass of either an isonitrogenous non-bioactive NEAA control beverage or a WPH (500 mL;
7.6% w/v) beverage within 5 min (Table 1). As aminoacidemia and MPS have been previously
shown to peak between 45–90 min following protein feeding [21,22], an additional blood sam-
ple was collected 60 min postprandial.
2.3 Amino acid analysis
Plasma amino acid (AA) profile of each participant at 0 and 60 min postprandial was deter-
mined as reported previously [23] on the Agilent 1200 RP-UPLC system (Agilent Technolo-
gies, Santa Clara, CA, USA) equipped with an Agilent 1260 binary pump and a G1367C
automated liquid handling system. AA separation, data acquisition and quantitative analysis
was performed as discussed previously [18].
2.4 Metabolic/Humoral biomarker analysis
Plasma insulin was determined using a commercial kit (Merck Millipore) on a MAGPIXTM
Multiplex reader and processed using Bio-Plex ManagerTM MP.
2.5 Cell culture
In vitro analysis was carried out using the murine skeletal muscle cell line C2C12. Cells were
cultured, sub-cultured and differentiated (up to 7 d) in DMEM medium as previously
described [18,24]. Prior to treatment with media conditioned by human serum, fully differen-
tiated myotubes were nutrient deprived in an AA and serum free DMEM medium (US biolog-
ical, Salem, MA, USA), supplemented with 1 mM sodium pyruvate (GE Healthcare, Thermo-
Fisher), 1% (v/v) penicillin/streptomycin solution, 1 mM L-glutamine, 6 mM D-glucose
(Sigma-Aldrich), and 34 mM NaCl (Sigma-Aldrich) (pH 7.3).
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2.6 Muscle protein synthesis
The surface sensing of translation technique (SUnSET) [25] was used to measure muscle pro-
tein synthesis in C2C12 myoutbes following treatment with media conditioned by ex vivo
human serum (fed or fasted). Differentiated and mature C2C12 myotubes were nutrient
deprived in AA and serum free DMEM medium for 1 h, following which they were treated
with media containing 20% human serum (fed or fasted) and 1 μM puromycin (Merck Milli-
pore Limited) for a further 4 h. The optimum nutrient deprivation time, puromycin, condi-
tioned media treatment time and percentage human serum used has been established
previously [18]. MPS and protein signalling was determined from cell lysates as described pre-
viously [18,24] and detailed below.
2.7 Immunoblotting
Protein lysates (30 μg) were denatured and separated by gel electrophoresis using 4–15% linear
gradient SDS-PAGE precast gels (Mini-Protean TGX Stain-free, Bio-Rad 456–8083). Follow-
ing electrophoresis, total protein (loading control) in each lane of the gel was determined
Table 1. Composition of WPH and isonitrogenous NEAA. Dose scaled per kg body mass (0.33 g.kg-1), and amount
reported typical for an 80 kg participant. BCAA, branched chain amino acids; EAA, essential amino acids; NEAA,
non-essential amino acids; AA, amino acids.
WPH NEAA Control
Energy (kJ) 545 442
Degree of hydrolysis (%) 13.1 0
Macronutrient Content
Protein or AA (g) 26.4 26.4
Carbohydrate (g) 1.6 0
Fat (g) 2.0 0
EAA
Leucine (g) 2.9 0
Isoleucine (g) 1.7 0
Valine (g) 1.6 0
Histidine (g) 0.5 0
Lysine (g) 2.6 0
Methionine (g) 0.6 0
Phenylalanine (g) 0.9 0
Threonine (g) 2.0 0
Tryptophan (g) 0.5 0
NEAA
Alanine (g) 1.4 2.7
Arginine (g) 0.7 0
Aspartic Acid (g) 3.0 3.2
Cysteine (g) 0.7 0
Glutamic Acid (g) 4.9 9.6
Glycine (g) 0.5 1.1
Proline (g) 1.7 4.3
Serine (g) 1.4 3.6
Tyrosine (g) 0.8 2.0
Total BCAA (g) 6.3 0
Total EAA (g) 13.3 0
Total NEAA (g) 15.1 26.4
https://doi.org/10.1371/journal.pone.0220757.t001
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using stain-free UV-induced fluorescence that activates tryptophan residues on the gel (UVI-
TEC Cambridge Imaging system, UVITEC, Cambridge, UK). Semi-dry transfer technique
(Trans-blot1 TurboTM Bio-Rad) was adapted to transfer proteins from the UV-activated gel
onto a 0.2 μm nitrocellulose membrane. Membranes were probed with the primary antibodies
(1:1000, dissolved in 5% BSA + TBST (0.05% Tween)) for puromycin (MABE343 anti-puro-
mycin, clone 12D10 mouse monoclonal, Merck Millipore Limited), phosphorylated-4E-BP1
(Thr37/46) (#2855), 4E-BP1 (#9644), phosphorylated-P70S6K (Thr389) (#9234), P70S6K
(#2708), phosphorylated-mTOR (Ser2448) (#2971), mTOR (#2972) and the reference protein
β-actin (Cell Signaling). Protein quantification was determined using fluorescence, and mem-
branes were probed with IRDye1 800CW anti-rabbit secondary antibody (1:10000, dissolved
in 5% BSA + TBST (0.05% Tween)) (926–32211, LI-COR Biosciences UK Ltd, UK) for all
proteins except puromycin where IRDye 800CW goat anti-mouse IgG2a-specific (LI-COR
Biosciences UK Ltd) secondary antibody was used. Images were captured in the UVITEC
Cambridge Imaging system (UVITEC, Cambridge, UK) and single band and whole-lane
(puromycin and total protein) band densitometry was conducted using NineAlliance UVITEC
Software (UVITEC, Cambridge, UK). Following probing with phospho- antibodies, mem-
branes were stripped according to the manufacturer’s instructions (Millipore, #2504) before
re-probing with pan antibodies. For quantification, phosphorylated proteins were normalised
to their respective total protein, puromycin was normalised to the total protein as determined
from the stain-free lane density.
2.8 Statistical analysis
GraphPad Prism v7.03 was used for statistical analysis. Data were tested for normality (Sha-
piro-Wilk test) and homogeneity of variances (Levene’s test). Paired Samples T-tests were used
to analyse differences in the plasma [insulin] and [AA] between fasted and fed human condi-
tion. 2-Way Repeated Measures ANOVA were used to establish main effects followed by
Tukey’s multiple comparisons post-hoc where main effects were evident. Paired sample T-Test
were used post-hoc to establish if media conditioned by human serum sampled post-ingestion
of the NEAA formulation resulted in increased intracellular signalling and MPS in C2C12
myotubes and un-paired sample T-Test to establish if these effects were different to the effect
of media conditioned by human serum sampled post-ingestion of WPH. The level of signifi-
cance was set at 95% (p< 0.05).
3. Results
Plasma [insulin] and [AA] following an overnight fast and 60 min following WPH or NEAA
ingestion (0.33 g.kg-1 body mass) are presented in Table 2. Relative to fasting, {AA] increased
significantly following WPH ingestion (p<0.05) and only[NEAA] and [threonine]increased
following ingestion of NEAA (p<0.05) (Table 2). Total [EAA] increased by 97% following
WPH ingestion but remained at fasted levels following ingestion of NEAA. Total [NEAA]
increased 34% and 55% following WPH and NEAA ingestion, respectively. Plasma [insulin]
increased by 44% following WPH (p<0.05) and 41% following NEAA ingestion (p<0.05).
A 2-Way ANOVA revealed a significant difference between conditions with main effects
for treatment (protein) and interaction (protein�feeding) (p<0.05). Cells treated with media
conditioned by WPH-fed serum observed significantly increased mTOR phosphorylation
(p<0.01) (Fig 1) relative to its corresponding fasted serum (Fig 1A and 1B). This increase in
mTOR phosphorylation was consistently observed in serum from each participant (n = 6) (Fig
1A). In comparison, NEAA-fed serum did not phosphorylate mTOR (Fig 1) which remained
at a similar level to its corresponding fasted serum (Fig 1A and 1B). Furthermore, when
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normalised to corresponding fasted serum (Fig 1B) mTOR phosphorylation in the WPH-fed
condition was significantly increased (p<0.01) compared to the NEAA-fed condition.
Stimulation of the downstream targets of mTOR activation, P70S6K and 4E-BP1, occurred
following treatment of C2C12 myotubes with media conditioned by serum (Fig 2). Like
mTOR, a 2-Way ANOVA revealed a significant difference between conditions (p<0.05) for
activation of P70S6K (main effect for feeding) (Fig 2A and 2B) and 4E-BP1 (main effects for
feeding and interaction protein�feeding) (Fig 2C and 2D), both of which were significantly
increased (p<0.05) in the WPH-fed condition relative to its corresponding fasted serum.
Comparatively, no change in P70S6K (Fig 2A and 2B) or 4E-BP1 (Fig 2C and 2D) phosphory-
lation relative to fasted, following treatment with media conditioned by NEAA-fed serum was
evident. This was consistently observed in each participant (Fig 2A and 2C). A significant
increase (p<0.05) in P70S6K (Fig 2B) and 4E-BP1 (Fig 2D) phosphorylation was observed in
media conditioned by WPH-fed compared to NEAA-fed serum (Unpaired T-test).
The SunSET technique [25] was adopted to verify that mTOR, P70S6K and 4E-BP1 activa-
tion led to an increase in MPS in skeletal muscle cells. A 2-Way ANOVA revealed a significant
difference between conditions (main effect for feeding) (p<0.05). No statistically significant
Table 2. Plasma insulin and amino acid at baseline (0 min) and postprandial (60 min). EAA, essential amino acids; NEAA, non-essential amino acids.
WPH NEAA Control
Time (min) 0 60 Δ (0–60) 0 60 Δ (0–60)
Humoral Biomarkers
Insulin (pM) 92 ± 33 133±38� 41 ± 14 67 ± 26 95 ± 31� 28 ± 6
EAA (μmol/L)
Leucine 127 ± 5 333 ± 11� 207 ± 11 151 ± 13 138 ± 10 -13 ± 7#
Isoleucine 63 ± 5 195 ± 11� 133 ± 8 74 ± 8 67 ± 6 -7 ± 4#
Valine 228 ± 7 398 ± 10� 170 ± 9 246 ± 16 242 ± 12 -5 ± 9#
Histidine 77 ± 2 91 ± 4� 14 ± 3 83 ± 5 85 ± 4 2 ± 3#
Lysine 183 ± 8 363 ± 17� 180 ± 13 172 ± 14 183 ± 14 11 ± 6#
Methionine 22 ± 3 45 ± 2� 23 ± 4 26 ± 2 26 ± 2 0 ± 1#
Phenylalanine 53 ± 2 71 ± 3� 18 ± 1 57 ± 5 51 ± 11� -6 ± 2#
Threonine 117 ± 12 230 ± 14� 112 ± 5 108 ± 9 151 ± 11� 44 ± 4#
Tryptophan 67 ± 4 124 ± 7� 57 ± 5 72 ± 8 71 ± 6 -1 ± 4#
Total EAA (μmol/L) 936 ±28 1849 ±45� 914 ± 41 989 ± 67 1013 ± 55 24 ± 37#
± 37
NEAA (μmol/L)
Alanine 267 ± 33 416 ± 40� 148 ± 12 326 ± 37 571 ± 56� 245 ± 20#
Arginine 76 ± 5 127 ± 9� 52 ± 7 80 ± 9 79 ± 8 -1 ± 5#
Asparagine 125 ± 8 187 ± 12� 62 ± 5 131 ± 20 255 ± 18� 125 ± 22#
Aspartic acid 0 ± 0 4 ± 1� 3 ± 1 0 ± 0 11 ± 2� 11 ± 2#
Glutamine 547 ± 20 653 ± 37� 106 ± 20 616 ± 33 746 ± 43� 131 ± 23
Glutamic acid 48 ± 11 63 ± 7� 14 ± 6 36 ± 8 137 ± 13� 101 ± 12#
Glycine 215 ± 20 248 ± 24� 33 ± 6 186 ± 17 328 ± 30� 143 ± 15#
Tyrosine 62 ± 4 100 ± 6� 38 ± 3 60 ± 7 98 ± 11� 38 ± 5
Total NEAA (μmol/L) 1341 ± 59 1798 ± 72� 457 ± 18 1433 ± 92 2227 ± 126� 793 ± 66#
Total AA (μmol/L) 2276 ± 81 3647 ± 67� 1371 ± 33 2422 ± 149 3239 ± 175� 817 ± 97#
Data are Mean ± SEM (n = 6); NA: Not Available
�within groups p<0.05 and
#between groups p<0.05
https://doi.org/10.1371/journal.pone.0220757.t002
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increase in MPS occurred in skeletal muscle cells treated with media conditioned by NEAA-
fed or WPH-fed serum when compared to treatment with media conditioned by their corre-
sponding fasted serum (Fig 3). However, normalised to the corresponding fasted serum, sig-
nificantly greater MPS was detected in the cells treated with media conditioned by WPH-fed
compared with NEAA-fed serum (p<0.05) (Fig 3B).
4. Discussion
The importance of the use of appropriate negative controls in human MPS studies has recently
been emphasised by key opinion leaders in the field [5,6]. Many studies in these meta-analyses
report on the effects of amino acid and protein supplementation on MPS in humans which use
less appropriate controls [5,7,8]. In line with the scientific opinion of EFSA, that human inter-
vention studies assessing the effect of different proteins on physiological processes require an
isonitrogenous comparator, a NEAA-only containing formulation isonitrogenous to whey
protein, was fed to human participants in equal dose to a whey protein hydrolysate. Fed and
fasted serum was used to condition media of C2C12 myotubes and evaluate change in intracel-
lular signalling and MPS. Our findings show that media conditioned by WPH-fed serum stim-
ulated kinases of the mTOR pathway and MPS in vitro, however media conditioned by
NEAA-fed serum did not.
As expected, plasma EAA concentration, including leucine, were not significantly elevated
from fasting levels following NEAA ingestion, but were increased following WPH ingestion
(Table 2). Elevated plasma levels of EAA post protein feeding have previously been shown to
Fig 1. Phosphorylation of mTOR in response to treatment with media conditioned by ex vivo human serum (n = 6). C2C12 myotubes were nutrient
deprived for 1 h followed by treatment with media conditioned by fasted (fast) or 60 min postprandial (fed) ex vivo serum for 4 h. Postprandial serum was
obtained 1 h after ingesting WPH or isonitrogenous NEAA. Densitometric analysis of (A) mTOR phosphorylation before and after treatment with media
conditioned by WPH or NEAA-fed ex vivo serum and (B) relative to fasted ex vivo serum. (C) Representative immunoblot of mTOR phosphorylation,total
mTOR and β-Actin. Data reported as Mean±SEM relative to respective total proteins, ��within groups p<0.01, ##between groups p<0.01.
https://doi.org/10.1371/journal.pone.0220757.g001
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robustly increase MPS [15,26]. Rennie and colleagues reported that an increase of ~80 μmol/L
in extracellular leucine is required to increase MPS in vivo [27,28]. Here, we observed an
increase greater than ~200μmol/L for WPH-fed, however, this threshold was not reached in
NEAA-fed condition and likely explains the lack of activation of MPS in our model, confirm-
ing NEAA as an effective isonitrogenous non-bioactive control.
Several humoral factors may act individually or collectively to stimulate MPS. Whereas cir-
culating EAA are thought to be the primary drivers of MPS, protein ingestion has been shown
to induce an increase in insulin, which is deemed ‘permissive’ with respect to MPS [29]. In this
study, we report a small increase (~40–45%) in circulating insulin with ingestion of both WPH
and NEAA. As reviewed elsewhere [30] and following a recent meta-analysis [31], large
increases in MPS are due to EAA regulating anabolic responses, whereas insulin regulates
Fig 2. Phosphorylation of P70S6K and 4E-BP1 in response to treatment with media conditioned by ex vivo human serum (n = 6). C2C12 myotubes were
nutrient deprived for 1 h followed by treatment with media conditioned by ex vivo fasted (fast) or 60 min postprandial (fed) serum for 4 h. Postprandial serum
was obtained 1 h after ingesting WPH or isonitrogenous NEAA. Densitometric analysis of P70S6K and 4E-BP1 phosphorylation before and after treatment
with media conditioned by WPH or NEAA-fed serum (A, C) and relative to fasted serum (B, D). Representative immunoblots of phospho-P70S6K, phospho-
4E-BP1, their respective total proteins and β-Actin (E). Data reported as Mean±SEM relative to their respective total proteins �within groups p<0.05, #between
groups p<0.05.
https://doi.org/10.1371/journal.pone.0220757.g002
A non-essential amino acid formulation as a non-bioactive control in studies of muscle protein synthesis
PLOS ONE | https://doi.org/10.1371/journal.pone.0220757 November 19, 2019 8 / 13
anti-catabolic (MPB) responses independent of AA availability [30,31]. Insulin, even in low
concentrations as observed here (WPH: 133 ± 38; NEAA 95 ± 31), has been shown to attenuate
MPB in vivo [32], however, this is not thought to impact MPS (the focus of this paper) when
EAA delivery is not increased as in the case of the non-bioactive NEAA control. Consumption
of NEAA did result in insulin-mediated clearance of EAAs from the circulation with small
reductions in circulating EAAs ranging from 1–10%. As a result, we postulate that only an ele-
vation in circulating EAA would result in increased signalling and MPS in response to media
conditioned by ex vivo protein-fed serum. Therefore, in the absence of an increase in circulat-
ing EAA as observed here, we anticipate that an isonitrogenous NEAA formulation can act as
an effective non-bioactive control for further investigation of the effect of protein feeding on
MPS in this model.
Fig 3. MPS in response to treatment with media conditioned by ex vivo human serum (n = 6). C2C12 myotubes were nutrient deprived for 1 h followed by
treatment with ex vivo fasted (fast) or 60 min postprandial (fed) human serum for 4 h. Postprandial serum was obtained 1 h after ingesting WPH or
isonitrogenous NEAA. Densitometric analysis of (A) MPS before and after treatment with media conditioned by WPH or NEAA-fed serum and (B) relative to
fasted serum. (C) Representative immunoblot of MPS (measured by puromycin incorporation) relative to total protein (loading control). Data reported as
Mean±SEM, #between groups p<0.05.
https://doi.org/10.1371/journal.pone.0220757.g003
A non-essential amino acid formulation as a non-bioactive control in studies of muscle protein synthesis
PLOS ONE | https://doi.org/10.1371/journal.pone.0220757 November 19, 2019 9 / 13
The potential of media conditioned by ex vivo human serum fed with isonitrogenous
NEAA or WPH to activate MPS in C2C12 myotubes was measured by phosphorylation of
mTOR and its downstream molecular proteins P70S6K and 4E-BP1. Dickinson and colleagues
determined that activation of mTOR and its downstream signalling proteins P70S6K and
4E-BP1 is required for stimulation of human skeletal MPS by EAA [33]. Addition of NEAA-
fed serum to condition cell media did not stimulate mTOR, P70S6K or 4E-BP1 phosphoryla-
tion in C2C12 skeletal muscle cells. This confirms a lack of bioactivity for the activation of
MPS in the NEAA formulation. In comparison, media conditioned by WPH-fed serum signifi-
cantly increased phosphorylation of mTOR, P70S6K and 4E-BP1, expressed as absolute values
(Figs 1A, 2A and 2C), normalised relative to fasted serum (Figs 1B, 2B and 2D) and in com-
parison to NEAA-fed. These in vitro data confirm the bioactivity of WPH to activate MPS.
Furthermore, phosphorylation of mTOR, P70S6K and 4E-BP1 with media conditioned by
WPH-fed serum resulted in significantly greater stimulation of MPS than media conditioned
by NEAA-fed serum (Fig 3B), providing further validation of the NEAA formulation used in
this study as an isonitrogenous, non-bioactive control.
In this study, we have demonstrated that an isonitrogenous NEAA supplement can be used
as a non-bioactive control for MPS in protein feeding studies. As discussed, NEAA have previ-
ously been demonstrated not to be primarily responsible or required to stimulate MPS [1–
3,17]. Similarly, unlike a bioactive WPH supplement, the isonitrogenous non-bioactive NEAA
control used here did not alter protein signalling activity of mTOR, P70S6K and 4E-BP1 or
MPS levels relative to its corresponding fasted serum. This suggests that in acute feeding
studies, this isonitrogenous non-bioactive NEAA supplement can serve as an appropriate con-
trol. However, it should be noted as a limitation of this study that media conditioned by
WPH-fed serum did not result in a statistically significant increase compared its correspond-
ing fasted serum. Further studies should look to add EAA to fasting serum to further validate
this model.
5. Conclusions
In conclusion, we have proposed and demonstrated the use of an isonitrogenous NEAA con-
trol that does not affect levels of circulating biomarkers, does not mediate signalling through
the mTOR pathway and neither augments nor attenuates MPS when used to condition media
of skeletal muscle cells in vitro. We have also demonstrated that an isonitrogenous non-bioac-
tive NEAA control can be used as a comparator against a bioactive in this model. This study
also provides further evidence on the use of pre- and post-fed ex vivo human serum in regulat-
ing MPS in vitro.
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